Abnormal expression of estrogen receptor is associated with thin endometrium.


Journal

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
ISSN: 1473-0766
Titre abrégé: Gynecol Endocrinol
Pays: England
ID NLM: 8807913

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 20 2 2019
medline: 18 12 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

This study was conducted to investigate the association of estrogen receptor (ER) and progesterone receptor (PR) expressions with thin endometrium. Patients with endometrial thickness of less than 7 mm were classified as the study group, while the control group was comprised of patients with endometrial thickness of 7 to 14 mm. The expressions of ER and PR were detected with semi-quantitative immunohistochemical analysis, and the differences were compared between the two groups. The expression of ER was significantly decreased (p < .05) in the stromal cells of thin endometrium during both proliferative and secretory phases as compared to those of normal endometrium. Likewise, ER expression was found to be lower in the glandular cells of thin endometrium than those of normal endometrium during proliferative phase. However, no significant differences were observed for the expression of PR in both glandular and stromal cells between the two groups. Thin endometrium was associated with reduced expression of ER in stromal cells both during proliferative and secretory phase, but in glandular epithelial cells only during proliferative phase.

Identifiants

pubmed: 30777477
doi: 10.1080/09513590.2018.1554035
doi:

Substances chimiques

Receptors, Estrogen 0
Receptors, Progesterone 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

544-547

Auteurs

Mingxia Gao (M)

a Reproductive Medicine Hospital of the First Hospital of Lanzhou University , Lanzhou , China.
b Key Laboratory for Reproductive Medicine and Embryo of Gansu Province , Lanzhou , China.

Chong Cao (C)

c The First Clinical Medical College of Lanzhou University , Lanzhou , China.

Xuehong Zhang (X)

a Reproductive Medicine Hospital of the First Hospital of Lanzhou University , Lanzhou , China.
b Key Laboratory for Reproductive Medicine and Embryo of Gansu Province , Lanzhou , China.

Fabing Tang (F)

d Pathology Department of the First Hospital of Lanzhou University , Lanzhou , China.

Lihui Zhao (L)

a Reproductive Medicine Hospital of the First Hospital of Lanzhou University , Lanzhou , China.
b Key Laboratory for Reproductive Medicine and Embryo of Gansu Province , Lanzhou , China.

Sisi Luo (S)

c The First Clinical Medical College of Lanzhou University , Lanzhou , China.

Lifei Li (L)

b Key Laboratory for Reproductive Medicine and Embryo of Gansu Province , Lanzhou , China.
c The First Clinical Medical College of Lanzhou University , Lanzhou , China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH